Document is current
Any future updates will be listed below
-
Authors
Aubert, Carole E.
Liabeuf, Sophie
Amouyal, Chloé
Kemel, Salim
Lajat-Kiss, Frédérique
Lacorte, Jean-Marc
Halbron, Marine
Carlier, Aurélie
Salem, Joe-Elie
Funck-Brentano, Christian
Perisic Matic, Ljubica
Witasp, Anna
Stenvinkel, Peter
Phan, Franck
Massy, Ziad A.
Hartemann, Agnès
Bourron, Olivier https://orcid.org/0000-0001-7348-7161
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02431234 at ClinicalTrials.govDocuments that mention this clinical trial
Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy
https://doi.org/10.1186/s13098-019-0429-7
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study
https://doi.org/10.1186/s12933-020-01122-4
Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study
https://doi.org/10.1186/s12933-025-02705-9
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts
https://doi.org/10.1186/s12933-024-02161-x
-
Funding
Funding for this research was provided by:
The vascular research activities of LPM, AW and PS were supported by the EU-funded INTRICARE consortium (ITN-EJD 722609)
doctoral research scholarship from the University of Lausanne
- License Information
-
More Information
Article History
Received: 5 March 2019
Accepted: 17 April 2019
First Online: 29 April 2019
